Related Experiment Video
Updated: Oct 7, 2025
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Ferroptosis-Inducing Nanomedicine for Cancer Therapy
Yang Wang1,2,3, Tianfu Liu1,2,3,4, Xiang Li1,2,3,5
1Department of Chemistry, School of Forensic Medicine, China Medical University, Shenyang, China.
Abstract:
Ferroptosis, a new iron- and reactive oxygen species-dependent form of regulated cell death, has attracted much attention in the therapy of various types of tumors. With the development of nanomaterials, more and more evidence shows the potential of ferroptosis combined with nanomaterials for cancer therapy. Recently, there has been much effort to develop ferroptosis-inducing nanomedicine, specially combined with the conventional or emerging therapy. Therefore, it is necessary to outline the previous work on ferroptosis-inducing nanomedicine and clarify directions for improvement and application to cancer therapy in the future. In this review, we will comprehensively focus on the strategies of cancer therapy based on ferroptosis-inducing nanomedicine currently, elaborate on the design ideas of synthesis, analyze the advantages and limitations, and finally look forward to the future perspective on the emerging field.
Insights
Ferroptosis, a cell death pathway, combined with nanomedicine shows promise for cancer therapy. This review explores ferroptosis-inducing nanomedicine strategies, design, and future applications in oncology.
Area of Science:
- Biomedical Engineering
- Nanomedicine
- Oncology
Background:
- Ferroptosis is an iron- and reactive oxygen species-dependent regulated cell death pathway.
- Ferroptosis has emerged as a promising therapeutic strategy for various cancers.
- Nanomaterials offer versatile platforms for developing ferroptosis-inducing nanomedicine.
Purpose of the Study:
- To comprehensively review current strategies for cancer therapy based on ferroptosis-inducing nanomedicine.
- To elaborate on the design principles and synthesis of ferroptosis-inducing nanomedicine.
- To analyze the advantages and limitations of existing approaches and discuss future perspectives.
Main Methods:
- Literature review of studies on ferroptosis-inducing nanomedicine for cancer therapy.
- Analysis of synthesis strategies and design concepts for nanomedicine.
- Evaluation of current applications, advantages, and limitations.
Main Results:
- Nanomaterials can be designed to induce ferroptosis for cancer treatment.
- Combination therapies involving ferroptosis-inducing nanomedicine show potential.
- Various strategies exist for synthesizing and applying these nanomedicines.
Conclusions:
- Ferroptosis-inducing nanomedicine is a rapidly developing field with significant therapeutic potential for cancer.
- Further research is needed to optimize nanomedicine design and overcome limitations for clinical translation.
- Future directions include exploring novel materials and combination therapies for enhanced efficacy.
More Related Videos
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
